3 Growth Stocks for the Long Term
Long-term growth can charge your portfolio, and these companies have what it takes to be dominant in their industries.
If You're Retired, Consider Buying These 3 Stocks
General Electric, Kinder Morgan, and Brookfield Property Partners should deliver steadily growing dividends, which makes them perfect for income investors' portfolios.
Here's What to Do If Your Identity Is Stolen
The Equifax data breach just raised the odds you'll be a fraud victim.
20 Years Later, Tom and David Gardner Talk Beginner Investing and The MFIG
Tom and David Gardner recently sat down to talk about what they've learned in their 20-plus years helping the world invest better and what readers can expect in the updated Motley Fool Investment Guide.
Not all job changes involve a promotion and raise. Here's why a lateral move can also make sense.
Find out how these winners have stayed under the radar -- for now.
Melco Resorts has a presence in some of the most attractive gaming markets in the world, but that doesn't mean it's a great stock to buy today.
P&G lays out its closing argument against an activist investor's proxy challenge.
It's not about the cost, but about the opportunity lost.
They mine for thermal coal in the same region, but high debt levels have left one partnership in a deep hole.
The graphics-chip specialist is at the center of various tech trends, but the stock has broken the wrong kind of record.
A growing number of millennials are failing to put any real thought into their financial goals, while most are unhappy with their finances at present. And that paints a pretty bleak picture.
The market is at a record high, but these stocks are trading at a discount.
Good things come in threes. Here are three solid stocks in three different industries with greater than 3% yields.
Will the good times keep rolling for Abeona Therapeutics, BeiGene, and Vanda Pharmaceuticals?
Here's how the newest addition to the home improvement retailer's empire is paying off.
Illumina, Mazor Robotics, and Novocure are on the cutting edge of healthcare innovation. That could make them perfect stocks to own in growth portfolios.
Keep these factors in mind when you think about Social Security. They'll lead you to a better filing strategy.
A bank, a tech company, and a huge pharmaceutical player are all still buys.
Long-term investors have no time to concern themselves with short-term issues.
Shareholders can measure the ROI of Gilead Sciences' Kite Pharma acquisition not in years, but in days.
Apple has been ridiculed for the stagnation of its artificial intelligence compared to other technology giants, but the AI on its latest iPhone just vaulted the competition.
Hint: Think solar energy, robots, and more robots.